Skip to main content
Top
Published in: Journal of Gastroenterology 12/2009

01-12-2009 | Original Article—Liver, Pancreas, and Biliary Tract

A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff

Authors: Noriko Oza, Yuichiro Eguchi, Toshihiko Mizuta, Eriko Ishibashi, Yoichiro Kitajima, Hiroko Horie, Michiko Ushirogawa, Takeko Tsuzura, Shunya Nakashita, Hirokazu Takahashi, Yasunori Kawaguchi, Yasutomo Oda, Ryuichi Iwakiri, Iwata Ozaki, Takahisa Eguchi, Naofumi Ono, Kazuma Fujimoto

Published in: Journal of Gastroenterology | Issue 12/2009

Login to get access

Abstract

Background

Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of the metabolic syndrome. The aim of this study was to evaluate a 6-month home-based lifestyle modification intervention delivered in collaboration with physicians, hygienists, registered dietitians, and nurses.

Methods

Outpatients with NAFLD diagnosed by abdominal ultrasonography were eligible for this study. Abdominal computed tomography (CT) scan evaluated liver fat deposition by the liver–spleen ratio (L/S ratio) and visceral fat accumulation as the visceral fat area (VFA; cm2). During the 6-month home-based lifestyle modification intervention, each patient was examined by physicians, nurses, hygienists, and registered dietitians, who provided individualized advice to the patients. Patients recorded their daily weight for self-control of weight with recommended diet and exercise regimens.

Results

Sixty-seven NAFLD patients were enrolled in this study and 22 patients (32.8%) completed the 6-month intervention. Nineteen of the 22 patients achieved significant improvements in body weight, body mass index (BMI), waist circumference, VFA, L/S ratio, and systolic blood pressure, with improved laboratory data. Overall, 39 patients withdrew from the intervention. The mean age of the patients who withdrew was 50.0 ± 11.0 years, which was significantly younger than that of the patients who were followed up (60.1 ± 10.1 years; P < 0.01).

Conclusions

The reduction in body weight achieved by NAFLD patients during the 6-month intervention was associated with improved fat deposition and liver function. This intervention offers a practical approach for treating a large number of NAFLD patients with lifestyle modification therapy.
Literature
1.
go back to reference Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of non-alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134–40.CrossRefPubMed Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of non-alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134–40.CrossRefPubMed
2.
go back to reference Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;129:375–8.CrossRefPubMed Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;129:375–8.CrossRefPubMed
3.
go back to reference Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, et al. One-year intense nutritional counseling results in histological improvement in patients with nonalcoholic steatohepatitis: a pilot study. Am J Gastroenterol. 2005;100:1072–81.CrossRefPubMed Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, et al. One-year intense nutritional counseling results in histological improvement in patients with nonalcoholic steatohepatitis: a pilot study. Am J Gastroenterol. 2005;100:1072–81.CrossRefPubMed
4.
go back to reference Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A, et al. Effects of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol. 2005;43:1060–6.CrossRefPubMed Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A, et al. Effects of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol. 2005;43:1060–6.CrossRefPubMed
5.
go back to reference Riley P, Sudarshi D, Johal M, Benedict A, Panteli J, Crook M, et al. Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study. Int J Clin Pract. 2008;62:374–81.CrossRefPubMed Riley P, Sudarshi D, Johal M, Benedict A, Panteli J, Crook M, et al. Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study. Int J Clin Pract. 2008;62:374–81.CrossRefPubMed
6.
go back to reference Tamura Y, Tanaka Y, Sato F, Choi JB, Watada H, Niwa M, et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab. 2005;90:3191–6.CrossRefPubMed Tamura Y, Tanaka Y, Sato F, Choi JB, Watada H, Niwa M, et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab. 2005;90:3191–6.CrossRefPubMed
7.
go back to reference Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003;22:2082–90.CrossRef Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003;22:2082–90.CrossRef
8.
go back to reference Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in fatty liver disease. Gastroenterology. 2002;123:745–50.CrossRefPubMed Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in fatty liver disease. Gastroenterology. 2002;123:745–50.CrossRefPubMed
9.
go back to reference de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R, Gonzalez JM. Effect of a hypocaloric diet on transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diabetes Res Clin Pract. 2008;79:74–8.CrossRefPubMed de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R, Gonzalez JM. Effect of a hypocaloric diet on transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diabetes Res Clin Pract. 2008;79:74–8.CrossRefPubMed
10.
go back to reference Fujimoto K, Sakata T, Etou H, Fukagawa K, Ookuma K, Terada K, et al. Charting of daily weight pattern reinforces maintenance of weight reduction in moderately obese patients. Am J Med Sci. 1992;303:145–50.CrossRefPubMed Fujimoto K, Sakata T, Etou H, Fukagawa K, Ookuma K, Terada K, et al. Charting of daily weight pattern reinforces maintenance of weight reduction in moderately obese patients. Am J Med Sci. 1992;303:145–50.CrossRefPubMed
11.
go back to reference Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(Suppl):S498–516.CrossRefPubMed Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(Suppl):S498–516.CrossRefPubMed
12.
go back to reference Nakagaichi M, Tanaka K. Development of a 12-min treadmill walk test at a self-selected pace for the evaluation of cardiorespiratory fitness in adult men. Appl Human Sci. 1998;17:281–8.CrossRefPubMed Nakagaichi M, Tanaka K. Development of a 12-min treadmill walk test at a self-selected pace for the evaluation of cardiorespiratory fitness in adult men. Appl Human Sci. 1998;17:281–8.CrossRefPubMed
13.
go back to reference Astrand PO, Rodahl K. Applied sports physiology. In: Astrand PO, Rodahl K, Dahl HA, editors. Textbook of work physiology. Physiological bases of exercise. 3rd ed. New York: McGraw-Hill; 1986. p. 646–82. Astrand PO, Rodahl K. Applied sports physiology. In: Astrand PO, Rodahl K, Dahl HA, editors. Textbook of work physiology. Physiological bases of exercise. 3rd ed. New York: McGraw-Hill; 1986. p. 646–82.
15.
go back to reference Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care. 1996;19:1138–41.CrossRefPubMed Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care. 1996;19:1138–41.CrossRefPubMed
17.
go back to reference Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome––a new worldwide definition. Lancet. 2005;366:1059–61.CrossRefPubMed Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome––a new worldwide definition. Lancet. 2005;366:1059–61.CrossRefPubMed
18.
go back to reference Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283–6.PubMed Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283–6.PubMed
19.
go back to reference Ishibashi E, Eguchi Y, Eguchi T, Matsunobu A, Oza N, Nakashita S, et al. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females. J Gastroenterol Hepatol. 2008;23:908–13.CrossRefPubMed Ishibashi E, Eguchi Y, Eguchi T, Matsunobu A, Oza N, Nakashita S, et al. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females. J Gastroenterol Hepatol. 2008;23:908–13.CrossRefPubMed
20.
go back to reference Ballentani S, Dalle Grave R, Suppini A, Marchesini G, Fatty Liver Italian Network. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology. 2008;47:746–54.CrossRef Ballentani S, Dalle Grave R, Suppini A, Marchesini G, Fatty Liver Italian Network. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology. 2008;47:746–54.CrossRef
21.
go back to reference Chan HL, de Silva HJ, Leung NW, Lim SG, Farrell GC, Asia-Pacific Working Party on NAFLD. How should we manage patients with non-alcoholic fatty liver disease in 2007? J Gastroenterol Hepatol. 2007;22:801–8.CrossRefPubMed Chan HL, de Silva HJ, Leung NW, Lim SG, Farrell GC, Asia-Pacific Working Party on NAFLD. How should we manage patients with non-alcoholic fatty liver disease in 2007? J Gastroenterol Hepatol. 2007;22:801–8.CrossRefPubMed
22.
go back to reference de Piano A, Prado WL, Caranti DA, Siqueira KO, Stella SG, Lofrano M, et al. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2007;44:446–52.CrossRefPubMed de Piano A, Prado WL, Caranti DA, Siqueira KO, Stella SG, Lofrano M, et al. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2007;44:446–52.CrossRefPubMed
23.
go back to reference Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J. 2007;334:299. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J. 2007;334:299.
Metadata
Title
A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff
Authors
Noriko Oza
Yuichiro Eguchi
Toshihiko Mizuta
Eriko Ishibashi
Yoichiro Kitajima
Hiroko Horie
Michiko Ushirogawa
Takeko Tsuzura
Shunya Nakashita
Hirokazu Takahashi
Yasunori Kawaguchi
Yasutomo Oda
Ryuichi Iwakiri
Iwata Ozaki
Takahisa Eguchi
Naofumi Ono
Kazuma Fujimoto
Publication date
01-12-2009
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 12/2009
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0115-x

Other articles of this Issue 12/2009

Journal of Gastroenterology 12/2009 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Clinical impact of radiotherapy for locally advanced pancreatic cancer

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.